• Contact
  • Press And News

Immune Health

 

Probiotic Lactic Yeast ® Kluyveromyces B0399: immune system stimulation, gut colonization, bifidobogenic effect and other strain specific, probiotic properties

Trial 143: Potential probiotic Kluyveromyces marxianus fragilis B0399 modulates the immune response in Caco-2 cells and PBMCs and impacts on the human gut microbiota in an in vitro colonic model syste

Children: Stimulation of the immune system by Kluyveromyces B0399® probiotic lactic yeast in the Sinerga product.

Trial 210. RETROSPECTIVE OBSERVATIONAL STUDY TO INVESTIGATE SINERGA, A MULTIFACTORIAL NUTRITIONAL PRODUCT, AND BACTERIAL EXTRACTS IN THE PREVENTION OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN INT

Atopic Dermatitis

Trial 75:The study involved ten patients with atopic dermatitis who were administered particular strains of lactic yeasts. At the end of the study the patients treated with KLUYVER B0399 (Kluyveromyce
2023. © All rights reserved. Laboratori Turval Italia srl (TURVAL Laboratories Ltd.) - Head Office and Research Dpt: Friuli innovazione (AREA international Science Park-TS), Via Linussio 51-33100 Udine (IT) – P. IVA 01883020305
We use cookies to enhance your browsing experience. If you want to disable cookies, please set your browser.